Skip to main content

European Human Biomonitoring Initiative

Deliverables

Revised set of key indicators (DOMG)

We will revise the set of indicators following the first 2.5 years of the initiative and add, delete or modify the previous indicators taking into account societal, scientific, policy and stakeholder perspectives. DOMG is an LTP to VITO and is responsible for this deliverable.

Prioritized list of known emerging chemicals (IRAS)

List of known chemicals (parent compounds or metabolites) to be considered as exposure markers of emerging concern. IRAS is an LTP to RIVM and is responsible for this deliverable.

Databases of candidate laboratories for the 2nd prioritization round of substances (ULPGC)

Database of the laboratories considered as candidate to perform the analysis of samples, to develop new methods and to support the QA/QC Program considering the substances included in the first round of prioritization. ULPGC is an LTP to ISCIII and is responsible for this deliverable.

List of criteria for selecting cohort studies

This deliverable will report on the criteria that will have be used to select data and samples needed for determining exposure-response associations for all priority substances.

2019 Programme of training activities, materials and capacity building mechanisms (RUMC)

The 2019 programme of training activities, materials and capacity building mechanisms will provide a time schedule for the activities planned for 2019. For each activity it will identify objectives linked to the AWP, partner/s responsible for delivering training, available training materials and the likely location of training (expect for online training). Links to any existing training activities at international level will also be identified, together with contact names. RUMC is an LTP to RIVM and is responsible for this deliverable.

1st update on the report on opportunities and obstacles of combining HBM and health studies, availability of health studies and administrative registers and guidelines

Update of the report under D11.1 adding new information about on-going/planned studies and updates to the SOPs based on the 2nd prioritization round.

Databases of candidate laboratories for the 1st prioritization round of substances (ULPGC)

Database of the laboratories considered as candidate to perform the analysis of samples, to develop new methods and to support the QA/QC Program considering the substances included in the first round of prioritization. ULPGC is an LTP to ISCIII and is responsible for this deliverable.

Prioritised list of biomarkers, matrices and analytical methods for the 2nd prioritization round of substances

A list with the selected biomarkers, matrices and analytical methods selected according to the criteria defined in task 9.1 and considering the substances included in the second round of prioritization.

2nd-priorisation-Report on survey design: Study protocols, SOPs and Guidelines, tailored and transferred questionnaires for recruitment and sampling

Detailed working documents are provided for recruitment and sampling for the study conduct for the second prioritized substances to close identified data gaps.

Report on approaches to identify mixture health effects (UBRUN)

This report provides a description of viable approaches to describe and assess mixture health effects for relevant mixtures identified under tasks 15.1 and 15.2 and proposes topical cases studies as proof of concept. UBRUN is an LTP to DH and is responsible for this deliverable.

Report on ongoing activities and existing data and data gaps for the 2nd prioritised substances including a list of metadata that can be uploaded in IPCheM (FMUL)

The existing information about the substances prioritised in the second prioritisation round (M18) on ongoing or within the next five years initiated or planned studies in the field of HBM (general population and occupational exposure) and health will be reported and data gaps identified. Metadata that can be uploaded in IPCheM will be compiled. FMUL is an LTP to FCT and is responsible for this deliverable. FMUL is an LTP to FCT and is responsible for this deliverable.

Initial report on occupational studies

Initial proposals and research plan for targeted occupational studies with EU added value on priority substances.

Template for AOP update report for selected priority substances

This deliverable will provide the comprehensive template that will have to be used to collect data on AOPs for the priority substances dealt with in HBM4EU. This will be fully compatible with the AOP KB of the OECD in order to ensure high level of coordination of the work done in WP13 with major international efforts in this domain.

First report on biobank activities (KI)

Report on progress made to access biobanked samples from across Europe and how these samples will be used to address data gaps. KI is an LTP to SEPA and is responsible for this deliverable.

1st Phased Action Plan for translation of HBM results into policy advise, measures and suggestions for further research at general level (UAntwerpen)

A generic canvas for policy interpretation of the HBM findings based on the input from EU policy board members; policy makers and stakeholders. UAntwerpen is LTP to VITO and is responsible for this deliverable.

2nd material for communication to participants, including informed consent

Necessary material to communicate with the participants are compiled and examples for the second prioritised substances provided.

Initial report on strategies adopted to align studies across Europe and preliminary results

Report on the national studies which will align, the processes to integrate the requiremns from HBM4EU to these national structures and any obstacles.

Description of national programmes

Description of national HBM programmes, which may align, to form a network for HBM4EU EJP.

2020 Strategy for the communication and dissemination of HBM4EU results

An update of the Strategy for the communication and dissemination of HBM4EU results to reflect the activities and outputs foreseen in the 2020 AWP.

Report on AOPs of priority substances

This deliverable will report on the preliminary AOPs derived for the 1st list of priority substances. The complete results of the AOP development work for the 1st list of priority substances will be included in the final report on AOPs (D13.5).

2nd substance-group specific risk assessment

2nd substance-group specific risk assessment based on HBM data of first round priority substances collected in HBM4EU.

Sustainability of HBM4EU in the future and related operational architecture concept: first report

This initial report will provide specific proposals for the future of the initiative based on our initial interactions with a large number of bodies. It will include the mechanisms of cooperation with DG RTD, the financial plans for 2021-2030, a governance structure and an institutional anchor at EU level.

Scoping documents for 2020

The scoping document will outline targeted research activities proposed for 2020 and designed to address policy questions regarding a specific substance or group of substances. The descriptions will include goals, activities to be undertaken, methods, expected output and results, assumptions, constraints and budget estimates, as well as addressing ethical issues for each of the prioritized substances.

1st substance-group specific derivation of EU-wide health based guidance values

Derivation of health based guidance value for first round priority substances based on existing data.

Scoping documents for 2019

The scoping document will outline targeted research activities proposed for 2019 and designed to address policy questions regarding a specific substance or group of substances. The descriptions will include goals, activities to be undertaken, methods, expected output and results, assumptions, constraints and budget estimates, as well as addressing ethical issues for each of the prioritized substances.

Criteria for prioritisation of biomarkers of effect (UGR)

List of criteria to select biomarkers of effect according to the type of study, the biological matrices where they have been developed, and to the analytical methods used in coordination to task 9.1. UGR is an LTP to ISCIII and is responsible for this deliverable.

Report on available biomarkers of effect of proven utility in human epidemiological studies for the 1st set of prioritised substances (UGR)

A list of biomarkers based on the human health effects, the quality of the assay and its usefulness for large population studies, which provide the most significant added value to HBM4EU by linking exposure data to measures of biological effects. This deliverable will also report on the outcome of the workshop organised in M18, as well as, the meta-analysis on existing data, if appropriate. UGR is an LTP to ISCIII and is responsible for this deliverable.

Report on estimation of relevant tissue and biological fluid doses of 1st set of priority compounds in the EU population using refined PBTK modeling

This report will provide estimates of the risk characterization ratios for the 1st set of priority substances based on the results of the quantitative estimates of exposure derived in task 12.2.a. In this context, any new regulatory thresholds discussed at the policy level for the 1st set of priority substances will be evaluated vis-à-vis the exposure estimates generated using the exposure reconstruction algorithms developed in HBM4EU.

2nd annual list of exposure distributions and/or EU-wide reference values

List of European reference values derived by analysis of consolidated data in IPCheM.

Inventory of available samples and data collected from existing cohorts and preliminary results on exposure-response associations for 1st list of priority substances

This deliverable will provide a comprehensive inventory of all previously collected samples and data (including the inventory prepared in WP7 and WP8) that will be available and useful for the derivation of robust exposure-response relationships for the 1st list of priority substances.

1st Report on analytical results and new methods development (IPA)

Results obtained by the qualified laboratories and the achievements and problems encountered during the development of new methods. IPA is an LTP to UBA and is responsible for this deliverable.

Statistical Analysis Plan for each substance group for 1st set of substances (ISGlobal)

The statistical analysis plan describes the statistical analyses that will be performed to test the hypotheses that are formulated as part of the study protocol for each of prioritized substances. ISGlobal is an LTP to ISCIII and is responsible for this deliverable.

Report information needs from policy makers translated in terms of functionality of HBM mixture information

This report describes the results of the consultation of information needs policymakers and stakeholders with respect to mixtures and gap analysis. The report will further outline the challenges and direction of research activities in Task 15.1, 15.2 and 15.3 to serve the information needs.

First report on targeted new fieldwork study results

Report on the new planned studies, the countries who will be involved and the material that has been prepared for these studies.

Scoping documents for 2018

The scoping document will outline targeted research activities proposed for 2018 and designed to address policy questions regarding a specific substance or group of substances. The descriptions will include goals, activities to be undertaken, methods, expected output and results, assumptions, constraints and budget estimates, as well as addressing ethical issues for each of the prioritized substances.

Report Outline and workplan for the joint survey on HBM mixtures (IRAS)

This report describes the gaps in existing data as identified under 15.1, the outcome of the CGL and MS and EC institutions’ consultation, and outlines the workplan for a joint HBM survey on mixtures in 3-5 MS. IRAS is an LTP to RIVM and is responsible for this deliverable.

Derivation of HBM guidance values for Cadmium

"Derivation of HBM guidance value for first round priority substances based on data collected through HBM4EU. The former deliverable with the title ""2nd substance-group specific derivation of HBM guidance values"" was split into 3 separate deliverables in order to ensure a high dissemination of information regarding the different HBM guidance values it is useful to have the derivation of different substances in separate documents: D5.6 – “Derivation of HBM guidance values for selected phthalates” (M28) D5.14 – “Derivation of HBM guidance values for Bisphenol A” (M28) D5.15 – “Derivation of HBM guidance values for Cadmium” (M28) "

1st annual list of exposure distributions and/or EU-wide reference values

List of European reference values derived by analysis of consolidated data in IPCheM.

Statistical analysis plan for the co-funded studies of WP8

The statistical working group (VITO, ANSP, UBA, ISGlobal) will elaborate a statistical analysis plan (SAP) for the co-funded studies of WP 8 by M39. The statistical analysis plan will be developed in close collaboration with researchers from the 1st and 2nd set substance group and CGLs as part of task 10.4.

Templates for the submission of urgent requests for new information, one for EU policy makers and one for national policy makers (ANSES)

The templates will provide a consistent approach to the submission of requests for action by HBM4EU under the rapid response mechanism. Templates will be produced for two communities, the EU policy community and the national policy makers. ANSES is LTP to INSERM and is responsible for this deliverable.

Report on the optimal methodology for exposure reconstruction from HBM data

This report will lay out the tiered methodology for exposure reconstruction from HBM data – the methodology will be structured in tiers on the basis of data availability and model estimation capacity for the compounds targeted in HBM4EU.

Revised Data Management Plan

The delivered data management plan (D 10.1) will be revised based on acquired experiences.

1st substance-group specific risk assessment

The first risk assessment will make use of already existing HBM data and will develop draft protocols for use in specific policy domains eg. food safety, chemical safety, occupational safety.

Second report on biobank activities (KI)

Report on progress with Biobanks – the establishment of permanent networks and links with HBM4EU. KI is an LTP to SEPA and is responsible for this deliverable.

Legal and Ethics Policy document (UCPH)

A legal, ethics, and intellectual property rights framework in parallel and in coordination with the Data Management Plan under task 10.1 to ensure that procedures for the collection, collation, transfer and use of HBM data fully respect data management and privacy legislation both at EU and at national level. UCPH is an LTP to NRCWE and is responsible for this deliverable.

Report real-life exposure profiles from re-analysis of existing HBM mixture data

The report describes available HBM mixture data and presents and discusses the results from the re-analysis of compiled database of existing HBM mixture data.

Report on biological half-lives of 2nd set of priority compounds (LSMU)

This report will provide the values of the biological half-lives of the 2nd set of priority compounds targeted in HBM4EU on the basis of the PBTK modeling results. The PBTK models will have been parameterized and upgraded based on the experimental data obtained in task 12.3.b. LSMU is an LTP to NPHSL and is responsible for this deliverable.

2017 Strategy for the communication and dissemination of HBM4EU results

The Strategy for the communication and dissemination of HBM4EU results will frame our key messages and identifying target audiences and relevant communication tools. The Strategy will include a publication plan, establishing a policy for the publication of articles in scientific journals, including such issues as authorship, as well as proposing processes to ensure that policy makers have access to results without undue delays caused by journal publication timeframes.

Report on progress targeted occupational studies

Report on strategies used to collate occupational data, results achieved, and further proposals with EU added value on priority substances.

Summary report on helpdesk activities

A first report summarising the helpdesk activities set up under the various work packages (task 6.2, task 8.5, task 9.6 and task 10.2) (D 2.8).

2018 Strategy for the communication and dissemination of HBM4EU results

An update of the Strategy for the communication and dissemination of HBM4EU results to reflect the activities and outputs foreseen in the 2018 AWP.

First set of key indicators (LNE Department)

We will develop a first set of indicators capturing societal, scientific, policy and stakeholder perspectives, to measure the performance and impacts of the HBM4EU. LNE Department is an LTP to VITO and is responsible for this deliverable.

Report on opportunities and obstacles of combining HBM and health studies, availability of health studies and administrative registers and guidelines

Report about what type of opportunities and obstacles were observed mainly in Germany, France and Israel when combining HBM and health studies, summary of the results to the questionnaires about on-going/planned health studies and administrative registers. SOPs for criteria for the use of existing biobanked samples for HBM analysis and guidelines for linking HBM and health studies

Report on biological half-lives of 1st set of priority compounds

This report will provide the values of the biological half-lives of the 1st set of priority compounds targeted in HBM4EU on the basis of the PBTK modeling results. The PBTK models will have been parameterized and upgraded based on the experimental data obtained in task 12.3.b.

Report on ongoing activities and existing data and data gaps for the 3rd prioritised substances including a list of metadata that can be uploaded in IPCheM (FMUL)

The existing information about the substances prioritized in the third prioritisation round (M42) on ongoing or within the next five years planned studies in the field of HBM (general population and occupational exposure) and health will be reported and data gaps identified. Metadata that can be uploaded in IPCheM will be compiled. FMUL is an LTP to FCT and is responsible for this deliverable.

1st Report on the content and use of the online library

The report will detail the structure, functionalities and content of the online library. It will also report on usage over the first 21 project months, based on the number of online users and downloads from the library.

Workflows for screening emerging chemicals (INRA)

Standardised workflows for broad “suspect chemical screening” of known emerging chemicals and for screening unknown emerging chemicals. INRA is an LTP to INSERM and is responsible for this deliverable.

Report on results of the selected biomarker of effect (UGR)

Experimental work: Report on results of the validation of specific biomarker of effect (i.e., ex vivo cell-based functional assays) in a set of available collected human samples from ongoing/current studies. UGR is an LTP to ISCIII and is responsible for this deliverable.

Report on ongoing activities and existing data and data gaps for the 1st prioritised substances including a list of metadata that can be uploaded in IPCheM (FMUL)

The existing information about the substances prioritised in the period of proposal preparation on ongoing or within the next five years initiated or planned studies in the field of HBM (general population and occupational exposure) and health will be reported and data gaps identified. Metadata that can be uploaded in IPCheM will be compiled. FMUL is an LTP to FCT and is responsible for this deliverable. FMUL is an LTP to FCT and is responsible for this deliverable.

3rd review of training methods (RUMC)

A third review of the training materials that have been produced and used under the HBM4EU training programme. This may include both materials developed by the HBM4EU teams, as well as materials developed under other relevant initiatives. RUMC is an LTP to RIVM and is responsible for this deliverable.

Identified gaps for the establishment of AOPs and required studies

This deliverable will report on the knowledge gaps identified in order to complete the establishment of AOPs for the 1st and 2nd list of priority substances in HBM4EU. It will also include a description of the studies (-omics, functional assays, etc.) necessary to complete the identified AOP knowledge gaps.

2020 Programme of training activities, materials and capacity building mechanisms (RUMC)

The 2020 programme of training activities, materials and capacity building mechanisms will provide a time schedule for the activities planned for 2020. For each activity it will identify objectives linked to the AWP, partner/s responsible for delivering training, available training materials and the likely location of training (expect for online training). Links to any existing training activities at international level will also be identified, together with contact names. RUMC is an LTP to RIVM and is responsible for this deliverable.

Statistical Analysis Plan for each substance group for 2nd set of substances (ISGlobal)

The statistical analysis plan describes the statistical analyses that will be performed to test the hypotheses that are formulated as part of the study protocol for each of prioritized substances. ISGlobal is LTP to ISCIII and is responsible for this deliverable.

List of biomarkers for the 1st set of prioritized substances (UGR)

Report of selected effect biomarkers selected for the 1st set of prioritised substances, including those that can provide integrated information on delineating the mode(s) of action (MOA) of the adverse response or toxicity. UGR is an LTP to ISCIII and is responsible for this deliverable.

Progress report on Report on strategies adopted to align studies across Europe and preliminary results

Report on which strategies have proved successful – and a set of preliminary reults will also include suggestion for improvement.

Strategy and SOPs for human sample exchange, including ethical demands (IBMT)

A strategy for the pan-European exchange of biobanked human samples is developed and laid down and SOPs including technical, legal and ethical requirements for the safe and standardized exchange elaborated. IBMT is an LTP to UBA and is responsible for this deliverable.

Second list of prioritised substances and proposed CGLs for 2019-2021 (ANSES)

The second list of prioritised substances will results from the prioritisation round from 2017 to 2018. It will identify substances that have been prioritised for inclusion in HBM surveys, analysis and/or research under HBM4EU in the three year period from 2019 to 2021. ANSES is LTP to INSERM and is responsible for this deliverable. ANSES is an LTP to INSERM and is responsible for this deliverable.

Prioritisation strategy and criteria (ANSES)

The prioritisation strategy will be transparent, credible and accountable and will set out the procedures by which substances will be prioritised for inclusion in HBM surveys, analysis and/or research under HBM4EU. Decisions regarding which substances to work on will be based on a set of criteria that capture both scientific evidence aspects, regulatory demands, societal concerns and take into account financial and technical feasibility. With regards to human exposure, the criteria will take into account environmental, consumer and occupational exposure pathways. ANSES is LTP to INSERM and is responsible for this deliverable. ANSES is LTP to INSERM and is responsible for this deliverable.

2018 Programme of training activities, materials and capacity building mechanisms (RUMC)

The 2018 programme of training activities, materials and capacity building mechanisms will provide a time schedule for the activities planned for 2018. For each activity it will identify objectives linked to the AWP, partner/s responsible for delivering training, available training materials and the likely location of training (expect for online training). Links to any existing training activities at international level will also be identified, together with contact names. RUMC is LTP to RIVM and is responsible for this deliverable.

2021 Strategy for the communication and dissemination of HBM4EU results

An update of the Strategy for the communication and dissemination of HBM4EU results to reflect the activities and outputs foreseen in the 2021 AWP.

2019 Strategy for the communication and dissemination of HBM4EU results

An update of the Strategy for the communication and dissemination of HBM4EU results to reflect the activities and outputs foreseen in the 2019 AWP.

1st Report on stakeholder consultation and mapping of needs

The report will summarise the outcomes of the 2017-2018 consultation on the prioritisation process, and will include a list of users of HBM4EU outputs and an inventory of gaps and needs, as well as the list of key terms and definitions. The report will be presented to the Governing Board and the Stakeholder Forum in support of the proposed list of priority substances and proposed CGLs.

Data management plan

The data management plan describes how existing and newly generated data are processed, managed, and quality controlled at the national level, harmonized, transferred and analysed at the European level and made available for different user communities.

1st material for communication to participants, including informed consent

Necessary material to communicate with the participants are compiled and examples for the first prioritised substances provided.

Criteria for prioritisation of biomarkers, matrices and analytical methods (ANSP)

A list of the criteria that will be applied in the prioritization process of the biomarkers and matrices for the target substances. They will be general criteria and therefore common for the all prioritization rounds. ANSP is an LTP to INSERM and is responsible for this deliverable.

The Quality Assurance/Quality Control Scheme in HBM4EU project (IPASUM)

Overview of the different approaches to be implemented in the HBM4EU project to cover the necessities in the different prioritization rounds. IPASUM is an LTP to UBA and is responsible for this deliverable.

2nd review of training methods (RUMC)

A second review of the training materials that have been produced and used under the HBM4EU training programme. This may include both materials developed by the HBM4EU teams, as well as materials developed under other relevant initiatives. RUMC is LTP to RIVM and is responsible for this deliverable.

Second report on targeted new fieldwork and results

Report on the first fieldwork results and the proposal and progress with the second field work following the second prioritisation round.

1st-priorisation-Report on survey design: Study protocols, SOPs and Guidelines, tailored and transferred questionnaires for recruitment and sampling

Detailed working documents are provided for recruitment and sampling for the study conduct for the first prioritised substances to close identified data gaps.

Prioritised list of biomarkers, matrices and analytical methods for the 1st prioritization round of substances

A list with the selected biomarkers, matrices and analytical methods selected according to the criteria defined in task 9.1 and considering the substances included in the first round of prioritization.

2021 Programme of training activities, materials and capacity building mechanisms (RUMC)

The 2021 programme of training activities, materials and capacity building mechanisms will provide a time schedule for the activities planned for 2021. For each activity it will identify objectives linked to the AWP, partner/s responsible for delivering training, available training materials and the likely location of training (expect for online training). Links to any existing training activities at international level will also be identified, together with contact names. RUMC is an LTP to RIVM and is responsible for this deliverable.

Establishment of Stakeholder Forum and Advisory Board

Selection criteria and members of Stakeholder Forum (SF) and Advisory Board (AB).

Review paper on PBTK/D models for the 1st set of priority compounds

This is a review paper (to be published in the peer-reviewed literature) on current state of the art in PBTK/D modeling regarding the 1st set of priority compounds – analysis of capabilities and limitations and need for further refinement.

Establishment of Governing Board

Governing Board (GB) members and terms of reference for its meetings.

Scoping documents for 2021

The scoping document will outline targeted research activities proposed for 2021 and designed to address policy questions regarding a specific substance or group of substances. The descriptions will include goals, activities to be undertaken, methods, expected output and results, assumptions, constraints and budget estimates, as well as addressing ethical issues for each of the prioritized substances.

Report on workshop about opportunities and obstracles for linking HBM and health studies

Report about feasibility workshop with agenda, list of participants, presenations of the workshop and summary of the outcome.

Selection criteria and inventory of effect biomarkers for the 2nd set of substances (UGR)

Classification of the biomarkers of effect into 3 categories. Reports of selected effect biomarkers selected for the 2nd set of prioritised substances, including those that can provide integrated information on delineation of the mode(s) of action (MOA) of the adverse response or toxicity, as well as those of utility in large epidemiological population studies. UGR is an LTP to ISCIII and is responsible for this deliverable.

Scoping paper on the development of an indicator on chemical exposure in the European population

The indicator will use HBM data for follow up of chemical exposure of the EU population.

1st review of training methods (RUMC)

A first review of the training materials that have been produced and used under the HBM4EU training programme. This may include both materials developed by the HBM4EU teams, as well as materials developed under other relevant initiatives. RUMC is LTP to RIVM and is responsible for this deliverable.

HBM4EU website

The HBM4EU website will promote the project and serve as an access point for results, including a link to IPCheM, as well as linking with other relevant projects. It will features an online library including technical materials on protocols and analytical methods, as well as training materials and guidance. It will also serve as an internal communication tool, featuring web pages for internal information sharing accessible via password. Continuous updates will ensure that the website is dynamic and effective as an information hub for the initiative.

Searching for OpenAIRE data...

Publications

Human biomonitoring as a tool to support chemicals regulation in the European Union

Author(s): Catherine Ganzleben, Jean-Philippe Antignac, Robert Barouki, Argelia Castaño, Ulrike Fiddicke, Jana Klánová, Erik Lebret, Nicolas Olea, Dimosthenis Sarigiannis, Greet R. Schoeters, Ovnair Sepai, Hanna Tolonen, Marike Kolossa-Gehring
Published in: International Journal of Hygiene and Environmental Health, Issue 220/2, 2017, Page(s) 94-97, ISSN 1438-4639
DOI: 10.1016/j.ijheh.2017.01.007

Prioritization of hazards of novel flame retardants using the mechanistic toxicology information from ToxCast and Adverse Outcome Pathways

Author(s): Lola Bajard, Lisa Melymuk, Ludek Blaha
Published in: Environmental Sciences Europe, Issue 31/1, 2019, ISSN 2190-4707
DOI: 10.1186/s12302-019-0195-z

Development of Policy Relevant Human Biomonitoring Indicators for Chemical Exposure in the European Population

Author(s): Jurgen Buekers, Madlen David, Gudrun Koppen, Jos Bessems, Martin Scheringer, Erik Lebret, Denis Sarigiannis, Marike Kolossa-Gehring, Marika Berglund, Greet Schoeters, Xenia Trier
Published in: International Journal of Environmental Research and Public Health, Issue 15/10, 2018, Page(s) 2085, ISSN 1660-4601
DOI: 10.3390/ijerph15102085

Physiology-based toxicokinetic modelling in the frame of the European Human Biomonitoring Initiative

Author(s): Dimosthenis A. Sarigiannis, Spyros Karakitsios, Elena Dominguez-Romero, Krystalia Papadaki, Celine Brochot, Vikas Kumar, Marta Schumacher, Moustapha Sy, Hans Mielke, Mathias Greiner, Marcel Mengelers, Martin Scheringer
Published in: Environmental Research, Issue 172, 2019, Page(s) 216-230, ISSN 0013-9351
DOI: 10.1016/j.envres.2019.01.045

Current EU research activities on combined exposure to multiple chemicals

Author(s): Stephanie K. Bopp, Robert Barouki, Werner Brack, Silvia Dalla Costa, Jean-Lou C.M. Dorne, Paula E. Drakvik, Michael Faust, Tuomo K. Karjalainen, Stylianos Kephalopoulos, Jacob van Klaveren, Marike Kolossa-Gehring, Andreas Kortenkamp, Erik Lebret, Teresa Lettieri, Sofie Nørager, Joëlle Rüegg, Jose V. Tarazona, Xenia Trier, Bob van de Water, Jos van Gils, Åke Bergman
Published in: Environment International, Issue 120, 2018, Page(s) 544-562, ISSN 0160-4120
DOI: 10.1016/j.envint.2018.07.037

A strategy to validate a selection of human effect biomarkers using adverse outcome pathways: Proof of concept for phthalates and reproductive effects

Author(s): Kirsten A. Baken, Nathalie Lambrechts, Sylvie Remy, Vicente Mustieles, Andrea Rodríguez-Carrillo, Christiana M. Neophytou, Nicolas Olea, Greet Schoeters
Published in: Environmental Research, Issue 175, 2019, Page(s) 235-256, ISSN 0013-9351
DOI: 10.1016/j.envres.2019.05.013

Human biomonitoring in health risk assessment in Europe: Current practices and recommendations for the future

Author(s): Henriqueta Louro, Milla Heinälä, Jos Bessems, Jurgen Buekers, Theo Vermeire, Marjolijn Woutersen, Jacqueline van Engelen, Teresa Borges, Christophe Rousselle, Eva Ougier, Paula Alvito, Carla Martins, Ricardo Assunção, Maria João Silva, Anjoeka Pronk, Bernice Schaddelee-Scholten, Maria Del Carmen Gonzalez, Mercedes de Alba, Argelia Castaño, Susana Viegas, Tatjana Humar-Juric, Lijana Kononenko
Published in: International Journal of Hygiene and Environmental Health, Issue 222/5, 2019, Page(s) 727-737, ISSN 1438-4639
DOI: 10.1016/j.ijheh.2019.05.009

Deciphering Adverse Outcome Pathway Network Linked to Bisphenol F Using Text Mining and Systems Toxicology Approaches

Author(s): Marylène Rugard, Xavier Coumoul, Jean-Charles Carvaillo, Robert Barouki, Karine Audouze
Published in: Toxicological Sciences, Issue 173/1, 2019, Page(s) 32-40, ISSN 1096-6080
DOI: 10.1093/toxsci/kfz214

Statement on advancing the assessment of chemical mixtures and their risks for human health and the environment

Author(s): Elina Drakvik, Rolf Altenburger, Yasunobu Aoki, Thomas Backhaus, Tina Bahadori, Robert Barouki, Werner Brack, Mark T.D. Cronin, Barbara Demeneix, Susanne Hougaard Bennekou, Jacob van Klaveren, Carsten Kneuer, Marike Kolossa-Gehring, Erik Lebret, Leo Posthuma, Lena Reiber, Cynthia Rider, Joëlle Rüegg, Giuseppe Testa, Bart van der Burg, Hilko van der Voet, A. Michael Warhurst, Bob van de Water, Ku
Published in: Environment International, Issue 134, 2020, Page(s) 105267, ISSN 0160-4120
DOI: 10.1016/j.envint.2019.105267

Cadmium Exposure and Risk of Breast Cancer by Histological and Tumor Receptor Subtype in White Caucasian Women: A Hospital-Based Case-Control Study

Author(s): Loreta Strumylaite, Rima Kregzdyte, Algirdas Bogusevicius, Lina Poskiene, Dale Baranauskiene, Darius Pranys
Published in: International Journal of Molecular Sciences, Issue 20/12, 2019, Page(s) 3029, ISSN 1422-0067
DOI: 10.3390/ijms20123029

Linking Bisphenol S to Adverse Outcome Pathways Using a Combined Text Mining and Systems Biology Approach

Author(s): Jean-Charles Carvaillo, Robert Barouki, Xavier Coumoul, Karine Audouze
Published in: Environmental Health Perspectives, Issue 127/4, 2019, Page(s) 047005, ISSN 0091-6765
DOI: 10.1289/ehp4200

Human biomonitoring in Israel: Recent results and lessons learned

Author(s): Tamar Berman, Rebecca Goldsmith, Hagai Levine, Itamar Grotto
Published in: International Journal of Hygiene and Environmental Health, Issue 220/2, 2017, Page(s) 6-12, ISSN 1438-4639
DOI: 10.1016/j.ijheh.2016.09.008

Setting up a collaborative European human biological monitoring study on occupational exposure to hexavalent chromium

Author(s): Tiina Santonen, Alessandro Alimonti, Beatrice Bocca, Radu Corneliu Duca, Karen S. Galea, Lode Godderis, Thomas Göen, Bruno Gomes, Ogier Hanser, Ivo Iavicoli, Beata Janasik, Kate Jones, Mirja Kiilunen, Holger M. Koch, Elizabeth Leese, Veruscka Leso, Henriqueta Louro, Sophie Ndaw, Simo P. Porras, Alain Robert, Flavia Ruggieri, Paul T.J. Scheepers, Maria J. Silva, Susana Viegas, Wojciech Wasowicz, A
Published in: Environmental Research, Issue 177, 2019, Page(s) 108583, ISSN 0013-9351
DOI: 10.1016/j.envres.2019.108583

Thyroid-disrupting chemicals and brain development: an update

Author(s): Bilal B Mughal, Jean-Baptiste Fini, Barbara A Demeneix
Published in: Endocrine Connections, Issue 7/4, 2018, Page(s) R160-R186, ISSN 2049-3614
DOI: 10.1530/EC-18-0029

Biomonitoring for Occupational Exposure to Diisocyanates: A Systematic Review

Author(s): Bernice Scholten, Laura Kenny, Radu-Corneliu Duca, Anjoeka Pronk, Tiina Santonen, Karen S Galea, Miranda Loh, Katriina Huumonen, Anne Sleeuwenhoek, Matteo Creta, Lode Godderis, Kate Jones
Published in: Annals of Work Exposures and Health, 2020, ISSN 2398-7308
DOI: 10.1093/annweh/wxaa038

Bisphenols and Oxidative Stress Biomarkers—Associations Found in Human Studies, Evaluation of Methods Used, and Strengths and Weaknesses of the Biomarkers

Author(s): Inger-Lise Steffensen, Hubert Dirven, Stephan Couderq, Arthur David, Shereen Cynthia D’Cruz, Mariana F Fernández, Vicente Mustieles, Andrea Rodríguez-Carillo, Tim Hofer
Published in: International Journal of Environmental Research and Public Health, Issue 17/10, 2020, Page(s) 3609, ISSN 1660-4601
DOI: 10.3390/ijerph17103609

Pesticides With Potential Thyroid Hormone-Disrupting Effects: A Review of Recent Data

Author(s): Michelle Leemans, Stephan Couderq, Barbara Demeneix, Jean-Baptiste Fini
Published in: Frontiers in Endocrinology, Issue 10, 2019, ISSN 1664-2392
DOI: 10.3389/fendo.2019.00743

Transcriptomic effect marker patterns of genotoxins – a comparative study with literature data

Author(s): Katrin Kreuzer, Falko Frenzel, Alfonso Lampen, Albert Braeuning, Linda Böhmert
Published in: Journal of Applied Toxicology, Issue 40/4, 2020, Page(s) 448-457, ISSN 0260-437X
DOI: 10.1002/jat.3928

A review of phthalate pharmacokinetics in human and rat: what factors drive phthalate distribution and partitioning?

Author(s): Elena Domínguez-Romero, Martin Scheringer
Published in: Drug Metabolism Reviews, Issue 51/3, 2019, Page(s) 314-329, ISSN 0360-2532
DOI: 10.1080/03602532.2019.1620762